A stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration, its preparation method and application

By designing a double-layer gel structure and regulating the level of reactive oxygen species, the problem of wounds being prone to infection and difficult to heal has been solved, and effective multi-stage healing of wounds has been achieved during the infection and repair periods.

CN117797309BActive Publication Date: 2026-11-17DERMATOLOGY HOSPITAL SOUTHERN MEDICAL UNIV (GUANGDONG PROVINCIAL DERMATOLOGY HOSPITAL GUANGDONG PROVINCIAL CENT FOR STI & SKIN DISEASES CONTROL & PREVENTION RES CENT FOR LEPROSY CONTROL & PREVENTION CHINA) +3
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202311795702.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-12-25
Publication Date
2026-11-17
Estimated Expiration
2043-12-25

AI Technical Summary

Technical Problem

Existing technologies struggle to effectively regulate reactive oxygen species levels during wound healing, leading to wounds that are prone to infection and difficult to heal. Furthermore, single-function materials cannot adequately address the entire wound healing process.

Method used

Employing a bilayer gel structure, comprising an upper hydrogel responsive to reactive oxygen species and a lower hydrogel loaded with stem cell vesicles containing AIE nanoparticles, it is formed through a click reaction, enabling programmed regulation of reactive oxygen species and tissue regeneration.

Benefits of technology

During wound infection, the lower hydrogel responds to hyaluronidase by releasing AIE@EVs vesicles for photodynamic sterilization, promoting wound repair; during the wound repair period, the upper hydrogel responds to excess ROS by reducing reactive oxygen species levels, promoting tissue regeneration, and achieving efficient wound healing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117797309B_ABST
    Figure CN117797309B_ABST
Patent Text Reader

Abstract

This invention discloses a stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species (ROS) and promote tissue regeneration, as well as its preparation method and applications. It is a bilayer gel comprising an ROS-responsive upper hydrogel and a lower hydrogel loaded with AIE nanoparticle-containing stem cell vesicles. The advantages of this invention include: during wound infection, the lower hydrogel can respond to excessive hyaluronidase in the wound by releasing AIE@EVs vesicles, generating a large amount of ROS for photodynamic sterilization, exhibiting excellent anti-infection and antibacterial functions, and promoting wound repair; the upper hydrogel can respond to excessive ROS, reducing tissue ROS levels, avoiding oxidative stress, reducing inflammatory responses, and promoting tissue regeneration, meeting the ROS levels required at different stages of wound healing, thus achieving the goal of programmatically regulating tissue ROS levels and combining wound tissue repair to achieve efficient wound healing.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of medical materials technology, and in particular to a stem cell vesicle hydrogel technology. Background Technology

[0002] Wound healing is a complex and dynamic process. Microenvironmental imbalance and pathological tissue regeneration can lead to prolonged wound healing and even serious complications such as sepsis and multiple organ failure, severely impacting patients' daily lives. Reactive oxygen species (ROS) in the microenvironment are central regulators of wound inflammation and oxidative stress, determining the wound healing process. During the infection phase, ROS generated by the inflammatory response can resist pathogen invasion and maintain wound homeostasis. However, during the wound repair phase, excessive accumulation of ROS can cause local oxidative stress, directly accelerating disease progression and deterioration. A "perfect" wound healing system should not only possess excellent tissue ROS regulation capabilities but also promote wound tissue regeneration by accelerating skin cell proliferation and re-epithelialization, and regulating collagen remodeling.

[0003] Currently, therapies targeting reactive oxygen species (ROS) mainly fall into two categories: one involves generating large amounts of ROS through photodynamic therapy to kill bacteria and promote the healing of infected wounds (Wen Haifei et al. Comprehensive Phototherapy: Single-component AIE points as multimodal therapeutic diagnostic agents for synergistic cancer therapy guided by fluorescence / photoacoustic imaging [J]. Biomaterials, 2021); the other involves using baicalin, hydrogels, cerium dioxide, etc., to remove excess ROS from tissues (Zhao Hua, Huang Jie et al. ROS-removing hydrogels can promote the healing of bacterially infected diabetic wounds [J]. Biomaterials, 2020). However, in clinical applications, the tissue environment is subtle and complex, and studies that only play a single role in wound healing cannot cover the entire process of wound healing. Therefore, it is crucial to construct a material that can programmatically regulate tissue ROS to meet the different needs of ROS levels in multiple processes of wound healing, and it has broader clinical application prospects.

[0004] Furthermore, research indicates that stem cells contain a large number of bioactive substances (such as DNA, proteins, and RNA), which can regulate inflammatory responses, promote angiogenesis, and facilitate tissue re-epithelialization through paracrine mechanisms, opening a new pathway for endogenous tissue remodeling in wounds. Compared to stem cells, stem cell vesicles have attracted widespread attention in tissue regeneration and repair due to their high stability, resistance to immune system rejection, and ability to carry large amounts of bioactive substances such as proteins, DNA, and RNA. However, wound healing is susceptible to factors such as bacterial infection and complex dynamic microenvironments, preventing this strategy from being widely applied as a mature technology. Exploring a dual wound healing strategy that programmatically regulates tissue ROS and promotes tissue remodeling is of great significance in addressing practical problems such as wound susceptibility to infection and difficulty in healing. Summary of the Invention

[0005] The purpose of this invention is to provide a stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration, as well as its preparation method and application, in order to solve the problems of easy infection and difficult healing of wounds in the prior art.

[0006] To achieve the above objectives, the present invention adopts the following technical solution:

[0007] A stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration is a bilayer gel comprising an upper reactive oxygen species responsive hydrogel (Gel 1) and a lower hydrogel (Gel 2) loaded with stem cell vesicles containing AIE nanoparticles.

[0008] The protein concentration of the AIE nanoparticle-containing stem cell vesicles ranges from 1 to 500 μg / mL. They are formed by the aggregation-induced emission of AIE nanoparticles encapsulated in artificial stem cell vesicles. The maximum concentration of AIE nanoparticles does not exceed 400 μmol / L, which is the maximum limit for AIE nanoparticle loading on the vesicles. Further increasing the concentration of AIE nanoparticles will cause a large amount of AIE nanoparticles to adhere to the Millipore polycarbonate membrane, and solid precipitates are easily formed, ultimately affecting the preparation of AIE nanoparticle-containing stem cell vesicles. The lower hydrogel, Gel 2, is formed by hydrogen bonding with sodium hyaluronate and loaded with AIE nanoparticle-containing stem cell vesicles.

[0009] The artificial stem cell vesicles are derived from one or more of adipose stem cells, bone marrow stem cells, and human umbilical cord mesenchymal stem cells.

[0010] Furthermore, the structural formula of the AIE molecule in the AIE nanoparticles is shown in formula (I):

[0011]

[0012] Furthermore, the reactive oxygen species responsive upper hydrogel Gel 1 is prepared by cross-linking a water-soluble polymer compound containing thiol groups, a water-soluble polymer compound containing alkynyl groups, and a reactive oxygen species responsive molecular compound containing amino functional groups via click reaction covalent bonds.

[0013] This invention also provides a method for preparing a stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration, the steps of which include:

[0014] S1. Preparation of AIE nanoparticles: DSPE-PEG solution was slowly added dropwise to a dimethyl sulfoxide solution containing AIE molecules under stirring. After stirring, the solution was dialyzed overnight, and AIE nanoparticles were collected.

[0015] Preparation of S2.AIE@EVs vesicles: After lysing stem cells to obtain cell membrane suspension, the cell membrane suspension was repeatedly ground, the supernatant was collected by centrifugation, and the supernatant was repeatedly squeezed and sieved using a liposome extruder to obtain artificial stem cell vesicles;

[0016] AIE nanoparticles and artificial stem cell vesicles are co-incubated and then sieved by reciprocating extrusion using a liposome extruder to achieve the encapsulation of AIE nanoparticles by artificial stem cell vesicles, thereby obtaining a stem cell vesicle solution containing AIE nanoparticles, also known as AIE@EVs vesicle solution.

[0017] S3. AIE@EVs vesicle solution was mixed with sodium hyaluronate powder and incubated, then allowed to stand and solidify to obtain a lower hydrogel loaded with AIE@EVs vesicles;

[0018] S4. Prepare a water-soluble polymer compound containing alkynyl groups. Mix a water-soluble polymer compound containing thiol groups, a water-soluble polymer compound containing alkynyl groups, and a reactive oxygen species responsive molecular compound containing amino functional groups, and then rapidly drop the mixture onto the lower hydrogel. Allow it to stand and solidify to obtain the stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote wound regeneration.

[0019] Preferably, the detailed preparation process of the S1.AIE nanoparticles includes: slowly adding 6 mL of a solution containing 6 mg DSPE-PEG to 300 μL of a dimethyl sulfoxide solution containing 2 mg AIE molecules under stirring conditions, stirring for 30 minutes, dialyzing overnight, and collecting AIE nanoparticles.

[0020] Preferably, the detailed preparation process of the S2.AIE@EVs vesicles includes: adding hypotonic cell lysis buffer to the stem cell suspension, lysing overnight at 4°C to obtain a cell membrane suspension, repeatedly grinding the cell membrane suspension, centrifuging at 3200g and 4°C for 5 minutes, taking the supernatant, and sequentially extruding and sieving it using a liposome extruder with Millipore polycarbonate membranes with pore sizes of 800nm ​​and 400nm to obtain artificial stem cell vesicles with a diameter of approximately 300nm; incubating AIE nanoparticles and artificial stem cell vesicles at a mass ratio of 2:1 at room temperature for 30 minutes, and then extruding and sieving them using a liposome extruder with a pore size of 200nm to achieve the encapsulation of AIE nanoparticles by the artificial stem cell vesicles, and purifying to obtain AIE@EVs vesicles with a diameter of approximately 100-200nm.

[0021] Preferably, the detailed process of S3 includes: using an AIE@EVs vesicle solution with a protein concentration of 1-500 μg / mL as a hydrogel precursor solution, mixing it with sodium hyaluronate powder at a mass ratio of 100:3-100:5, incubating at 37°C for 30 min, and then allowing it to stand at room temperature for 30 min to solidify. The lower hydrogel loaded with AIE@EVs vesicles is obtained by solidification through hydrogen bonding between the hydroxyl and carboxyl groups of sodium hyaluronate. The conditions are simple, requiring no external chemical reagents and avoiding additional steps. The formed hydrogel can respond to hyaluronidase produced by bacteria, achieving controlled release of AIE@EVs vesicles.

[0022] Preferably, the thiol-containing water-soluble compound has one of the following structures:

[0023]

[0024] Where n is an integer greater than or equal to 1;

[0025] The water-soluble polymer containing an alkyne group has one of the following structures:

[0026]

[0027] Where n is an integer greater than or equal to 1;

[0028] Reactive oxygen species responsive molecular compounds containing amino functional groups have one of the following structures:

[0029]

[0030] Preferably, the detailed process of S4 includes: mixing a water-soluble polymer compound containing thiol groups, a water-soluble polymer compound containing alkynyl groups, and a reactive oxygen species responsive molecular compound containing amino functional groups in a molar ratio of 1:0.3:0.35-1:0.5:0.125, mixing them under pH conditions of 7-9, and then rapidly dropping the mixture onto the lower hydrogel, allowing it to stand and solidify for 3 minutes to obtain the stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration;

[0031] The water-soluble polymer containing thiol groups is 8-arm-PEG-SH;

[0032] The alkyne-containing water-soluble polymer compound is PEG4000-DA, and its preparation process includes: dissolving 2.5 mmol of PEG-4000, 25 mmol of propargyl acid, and a catalytic amount of 1.5 mmol of p-toluenesulfonic acid in toluene, stirring the mixed solution and refluxing for 48 h, continuously removing the generated water, then concentrating the solution under vacuum, purifying it, and drying it under vacuum to obtain the alkyne-containing water-soluble polymer compound PEG4000-DA;

[0033] The reactive oxygen species-responsive molecular compound containing an amino functional group is TK-linker, and its structural formula is as follows:

[0034]

[0035] Where n is an integer greater than or equal to 1.

[0036] This invention also provides the application of stem cell vesicle hydrogels that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration in the preparation of wound repair and regeneration materials.

[0037] The advantages of this invention include: the hydrogel is simple and low in cost to prepare, and the AIE@EVs vesicles are relatively stable and easy to store. The AIE molecules possess outstanding reactive oxygen species (ROS) generation capabilities. During wound infection, the lower hydrogel can respond to excessive hyaluronidase in the wound by releasing AIE@EVs vesicles, generating a large amount of ROS for photodynamic sterilization, exhibiting excellent anti-infection and antibacterial functions, and promoting wound repair. AIE@EVs vesicles can carry various signaling molecules with stem cell functions, such as RNA, DNA, and proteins, as well as various paracrine factors, thus possessing stem cell functions. AIE@EVs vesicles regulate the functional activities between cells and tissues through direct cell contact or paracrine effects to maintain tissue microenvironment homeostasis and promote the remodeling of wound structure and function. When wound bacteria are damaged, during the wound repair period, the upper hydrogel Gel 1 can respond to excessive ROS, reduce tissue ROS levels, avoid oxidative stress, reduce inflammatory responses, promote tissue regeneration, accelerate wound re-epithelialization, and meet the ROS levels required at different stages of wound healing. This achieves the goal of efficient wound healing by programmably regulating the combination of wound tissue ROS levels and wound tissue repair. Attached Figure Description

[0038] The accompanying drawings, which are included to provide a further understanding of the invention and form part of this application, do not constitute an undue limitation of the invention. In the drawings:

[0039] Figure 1 This is the preparation equation for PEG4000-DA;

[0040] Figure 2 It is the equation for the click reaction of PEG4000-DA,TK-linker with 8-arm-PEG-SH involving thiol-alkyne and alkyne-amine;

[0041] Figure 3 This refers to the preparation process of stem cell vesicle hydrogels;

[0042] Figure 4 These are transmission electron microscope images of AIE@EVs;

[0043] Figure 5 These are characterization diagrams of the mechanical properties of stem cell vesicle hydrogels that can be programmed to regulate reactive oxygen species and promote tissue regeneration. a) shows the elastic modulus under different strain conditions, and b) shows the elastic modulus under different angular frequencies.

[0044] Figure 6 This is a characterization diagram of the drug sustained-release capacity of stem cell vesicle hydrogels that can programmatically regulate reactive oxygen species and promote tissue regeneration.

[0045] Figure 7 This is a characterization diagram of the reactive oxygen species generation capacity of stem cell vesicle hydrogels after degradation by hyaluronidase.

[0046] Figure 8 This is an experimental diagram showing the antibacterial ability of AIE@EVs against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus;

[0047] Figure 9 This is a characterization diagram of the reactive oxygen species scavenging ability of the hydrogel;

[0048] Figure 10 This is a graph showing the results of AIE@EVs promoting cell proliferation;

[0049] Figure 11 This is a diagram of a scratch test.

[0050] Figure 12 This is an experimental diagram illustrating the promotion of angiogenesis in HUVEC cells;

[0051] Figure 13 These are images showing the healing effects of burn wounds treated with different methods. Detailed Implementation

[0052] The present invention will now be described in detail with reference to the accompanying drawings and specific embodiments. The illustrative embodiments and descriptions of the present invention are used to explain the present invention, but are not intended to limit the present invention.

[0053] Example 1: Construction method of AIE@EVs vesicles

[0054] (1) Construction of AIE nanoparticles: DSPE-PEG solution (6 mg, 6 mL) was slowly added dropwise to a dimethyl sulfoxide solution (2 mg, 300 μL) containing AIE molecules (hereinafter referred to as AIE) under stirring. After stirring for 30 minutes, the solution was dialyzed overnight using a dialysis bag to collect AIE nanoparticles. The structural formula of the AIE molecule is shown in formula (I):

[0055]

[0056] (2) Preparation of AIE@EVs vesicles: Stem cells were obtained after culturing mouse mesenchymal stem cells to the third generation. After lysing the stem cells, stem cell vesicles were obtained by extrusion using a liposome extruder. The specific preparation steps are as follows:

[0057] a. Each vial of stem cells (5×10) 6 Add 0.5 mL of hypotonic cell lysis buffer to a suspension (resuspended in 0.5 mL PBS) and incubate overnight at 4 °C to lyse the cells and obtain a cell membrane suspension.

[0058] b. The cell membrane suspension obtained after lysis in step a was repeatedly ground 20 times using a tissue grinding pestle, centrifuged at 3200g and 4℃ for 5min to remove the precipitate (fragments of cytoplasm and organelles), and the supernatant was retained. The supernatant was then repeatedly squeezed and sieved using a mini liposome extruder with Millipore polycarbonate membranes with pore sizes of 800nm ​​and 400nm to convert the stem cell membrane into vesicles with a diameter of approximately 300nm for later use.

[0059] c. The vesicles with a diameter of approximately 300 nm were incubated with AIE nanoparticles at room temperature for 30 min, with a mass ratio of AIE nanoparticles to stem cell vesicles of 2:1. Using a Millipore polycarbonate membrane with a pore size of 200 nm, the membrane was repeatedly extruded and sieved through a mini liposome extruder to convert the adipose-derived stem cell membrane into vesicles with a diameter of approximately 100-200 nm for later use, thus completing the vesicle vesicle formation process. The obtained vesicles were purified using a 20 kDa ultrafiltration membrane to remove components not encapsulated in the vesicle structure, yielding a pure AIE@EVs vesicle solution. The final measured concentration of AIE nanoparticles in the AIE@EVs vesicles was approximately 80 μmol / L, and the protein concentration was 300 μg / mL.

[0060] Example 2: Preparation of stem cell vesicle hydrogels that can programmatically regulate reactive oxygen species and promote tissue regeneration

[0061] The upper gel mixture is dropped onto the lower hyaluronic acid gel to obtain a bilayer gel, abbreviated as Dual-Gel. The specific preparation steps are as follows:

[0062] a. Add 8 mg of commercially available sodium hyaluronate powder to a PBS suspension of 200 μL of AIE@EVs vesicles (with a protein concentration of 50 μg / mL), stir and mix, and incubate at 37°C for 30 min to dissolve the sodium hyaluronate. Then allow to stand at room temperature for 30 min to solidify, resulting in the lower hydrogel containing the AIE@EVs vesicles, abbreviated as Gel 2. The PBS suspension of AIE@EVs vesicles serves as the precursor solution, with a mass ratio of precursor liquid to sodium hyaluronate powder of 100:3-100:5.

[0063] b. Dissolve PEG-4000 (10 g, 2.5 mmol, commercially available), propargyl acid (1.75 g, 25 mmol, commercially available), and a catalytic amount of p-toluenesulfonic acid (0.29 g, 1.5 mmol, commercially available) in toluene. Stir the mixture and reflux for 48 h, continuously removing the water produced. Then concentrate the solution under vacuum to remove most of the solvent, precipitate the product with diethyl ether, recrystallize with isopropanol, and dry under vacuum to obtain the target product PEG4000-DA (a water-soluble polymer containing an alkynyl group). The preparation equation for PEG4000-DA is as follows: Figure 1 As shown.

[0064] c. Mix PEG4000-DA,TK-linker and 8-arm-PEG-SH at a molar ratio of 1:0.5:0.125 at pH 8, and rapidly drop the mixture onto the surface of the lower hydrogel. Allow it to stand and solidify for 3 minutes to obtain a stem cell vesicle hydrogel that programmatically regulates tissue reactive oxygen species and promotes tissue regeneration. The equations for the mercapto-alkyne and alkyne-amine click reactions between PEG4000-DA,TK-linker and 8-arm-PEG-SH are as follows: Figure 2 As shown, an upper hydrogel, abbreviated as Gel 1, is formed. The preparation process of the stem cell vesicle hydrogel is as follows: Figure 3 As shown.

[0065] Comparative Example 1

[0066] The difference between the process of preparing vesicle solution in this comparative example and that in Example 1 is that AIE nanoparticles were not added in step (2), and an artificial stem cell vesicle suspension without AIE nanoparticles was obtained.

[0067] Comparative Example 2

[0068] The difference between this comparative example and Example 1 is that the EVs suspension was mixed with the AIE molecule solution and incubated for 30 minutes before being repeatedly extruded. The preparation process revealed that, due to the strong hydrophobicity of AIE molecules, they could not be well dispersed, resulting in a large number of AIE molecules on the Millipore polycarbonate membrane, and ultimately, an extremely low concentration of AIE molecules in the obtained vesicles.

[0069] Comparative Example 3

[0070] The difference between this comparative example and Example 2 is that in step c, the molar ratio of PEG4000-DA, TK-linker and 8-arm-PEG-SH is 1:0.8:0.1. During the preparation process, it was observed that no gel was formed even after overnight treatment.

[0071] Test Example 1

[0072] The AIE@EVs of Example 1 and the EVs of Comparative Example 1 were characterized using transmission electron microscopy (TEM). Figure 4 As shown, AIE nanoparticles were successfully loaded into EVs with a particle size of approximately 100 nm.

[0073] The hydrogel prepared in Example 2 was characterized using a rheometer, such as... Figure 5 As shown in Figure a, Gel-1, Gel-2, and Dual-Gel exhibit significantly larger storage moduli G' than loss moduli G” in the low strain range (1%–100%), indicating that the hydrogels possess solid-like behavior under these strains. Furthermore, as Figure 5 As shown in Figure b, the angular frequency (0.1-40 rad / s) scanning experiment shows that the hydrogel remains within its elastic response range without cracking under 1% strain, and the storage modulus G' is much larger than the loss modulus G”, indicating that the hydrogel has good viscoelasticity. In summary, the hydrogel has good mechanical properties.

[0074] Test Example 2: Response-Sustained-Release Experiment of Stem Cell Vesicle Hydrogels that Procedurally Regulate Reactive Oxygen Species and Promote Tissue Regeneration

[0075] Gel-1, Gel-2 and Dual-Gel obtained in Example 2 were immersed in PBS solution containing hyaluronidase (>400 U / mL) of equal volume. Samples were taken at different time intervals, and the percentage of AIE@EVs sustained release by the hydrogel was calculated by detecting the concentration of released AIE nanoparticles.

[0076] Figure 6 This is a characterization diagram of the drug release capacity of the stem cell vesicle hydrogel prepared in Example 2, which programsatically regulates reactive oxygen species and promotes tissue regeneration. Figure 6 It can be seen that, compared with Gel 1, the release of AIE@EVs by Gel 2 and Dual-Gel increased over time, which indicates that hyaluronidase conditions facilitate the targeted release of stem cell vesicle hydrogels at the site of wound infection.

[0077] Test Example 3: Test Experiment on the Reactive Oxygen Generation Capacity of Stem Cell Vesicle Hydrogels that Can Programmatically Regulate Reactive Oxygen Species and Promote Tissue Regeneration

[0078] Stem cell vesicle hydrogels can release AIE@EVs after degradation by hyaluronidase. After irradiation with a 633nm laser, the presence of reactive oxygen species (ROS) in the solution was detected using a DCFH (2',7'-dichlorodihydrofluorescein) probe as an indicator. The ROS generation capacity of the upper hydrogel, lower hydrogel, and stem cell vesicle hydrogel from Example 2 was tested as follows: 100 μL of DCFH aqueous solution was added to 900 μL of hydrogel degradation solution (40 μg / mL) and mixed thoroughly. The above solution was then subjected to a 200mW / cm² laser. 2 The hydrogel was excited by 633nm light, and its ability to generate reactive oxygen species was measured by detecting the change in fluorescence intensity at 525nm after every 20 seconds of illumination.

[0079] Figure 7 This image characterizes the reactive oxygen species (ROS) generation capacity of stem cell vesicle hydrogels after hyaluronidase degradation. Figure 7 It was found that the fluorescence intensity of the stem cell vesicle hydrogel degradation solution at 525 nm increased with the extension of light exposure time, indicating that the hydrogel degradation solution can effectively generate reactive oxygen species.

[0080] Test Example 4: Antibacterial Test of Stem Cell Vesicle Hydrogel with Programmable Regulation of Reactive Oxygen Species and Promotion of Tissue Regeneration

[0081] The antibacterial properties of AIE@EVs obtained in step (2) of Example 1 were tested, and the specific operation was as follows:

[0082] Add AIE@EVs (final concentrations of 0.5, 1, 2, and 4 μM) to Gram-positive bacteria (Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA)) (1×10⁻⁶). 6 In a solution containing CFU / mL, irradiate with light (633nm, 200mW / cm²) for 15 minutes. 2 (15 min), and then the bactericidal performance of AIE@EVs against bacteria was determined by streak plating.

[0083] Figure 8 This is a graph showing the antibacterial activity of AIE@EVs against methicillin-resistant Staphylococcus aureus and Staphylococcus aureus. Figure 8 It is known that AIE@EVs do not exhibit significant dark toxicity to these two bacteria, and their antibacterial ability is enhanced after light exposure. Therefore, the AIE@EVs of this invention can effectively kill bacteria.

[0084] Test Example 5: Test of the reactive oxygen species scavenging capacity of stem cell vesicle hydrogels that can programmatically regulate reactive oxygen species and promote tissue regeneration.

[0085] The stem cell vesicle hydrogel from Example 2 was subjected to a reactive oxygen species (ROS) scavenging capacity test. The specific procedure was as follows: 2,2'-azobis(3-ethylbenzothiazoline-6-sulfonic acid) free radical cations (ABTS) were prepared by mixing ABTS (1 mL, 7.4 mM aqueous solution, commercially available) with K2S2O8 (1 mL, 2.6 mg, commercially available). +· After being stored in the dark for 12 hours, ABTS was obtained. +· Working solution. Then, different weights of hydrogel and 20 μL of LABTS were mixed. +· The solution was sequentially added to vials containing 1200 μL PBS (pH = 7.4), with hydrogel concentrations of 5 mg / mL, 10 mg / mL, 15 mg / mL, 20 mg / mL, 25 mg / mL, and 30 mg / mL. The mixtures were incubated at room temperature for different times, and the effect of the hydrogel on ABTS was measured by detecting changes in absorbance at 734 nm. +· Its ability to clear debris.

[0086] Figure 9 This is a characterization diagram of the reactive oxygen species scavenging capacity of the stem cell vesicle hydrogel prepared in Example 2. Figure 9It can be observed that as the incubation time of the hydrogel is extended, the reactive oxygen species scavenging rate increases, indicating that the hydrogel can effectively remove reactive oxygen species.

[0087] Test Example 6: Experiments on cell proliferation, migration, and tubule formation promotion using stem cell vesicle hydrogels that can programmatically regulate reactive oxygen species and promote tissue regeneration.

[0088] Cell proliferation was promoted using AIE@EVs prepared in Example 1 and EVs in Comparative Example 1. The specific procedure was as follows: Human keratinocytes (HaCaT) were seeded in 6-well plates. After 24 hours, PBS, AIE nanoparticles, EVs, and AIE@EVs were added, respectively. After culturing for another 12 hours, staining was performed using an EDU kit, and cell proliferation was observed under a fluorescence microscope. Figure 10 As shown, with the introduction of EVs and AIE@EVs, the amount of newly synthesized DNA increased, indicating that EVs and AIE@EVs have a significant cell proliferation-promoting effect.

[0089] The migration performance of AIE@EVs prepared in Example 1 and EVs in Comparative Example 1 was tested, and the wound healing effect of AIE@EVs and EVs was evaluated in vitro using a scratch assay. The specific procedure was as follows: HaCaT cells were seeded into 6-well plates, and after 24 hours, lines were drawn and marked with a clean pipette tip. PBS, AIE, EVs, and AIE@EVs were added respectively. Microscopic images were taken at 0, 12, and 24 hours to observe the cell migration ability. Figure 11 As shown, compared with the PBS group and the AIE group, the scratch spacing of the EVs and AIE@EVs groups was significantly shortened over time, indicating that vesicles have a significant cell migration-promoting effect and help wound contraction.

[0090] AIE@EVs and EVs were used in a tube formation experiment. The specific procedure was as follows: 250 μl of low-growth factor matrix gel was added to a 24-well plate, and the plate was incubated at 37°C and 5% CO2 for 30 minutes to solidify the matrix gel. Human umbilical vein endothelial cell (HUVEC) suspensions (75,000 cells / mL) containing AIE nanoparticles, EVs, and AIE@EVs were then added to the solidified matrix gel. The 24-well plates were incubated at 37°C and 5% CO2 for three hours, followed by calcein staining and microscopic observation. Results are as follows: Figure 12 As shown, compared with the PBS group and the AIE group, the EVs and AIE@EVs groups showed significant tubule formation, indicating that vesicles have the potential to promote angiogenesis in HUVEC cells.

[0091] Test Example 7: In vivo wound healing experiment using stem cell vesicle hydrogels that can programmatically regulate reactive oxygen species and promote tissue regeneration.

[0092] After anesthetizing rats with isoflurane, their backs were shaved. The rats were then fixed to a clean bench, and a burn model was established using a YLS-5Q tabletop super-temperature controlled burn instrument at 90℃ and 500g for 10 seconds. The next day, an incision was made at the burn site, and 20 μL (1×10⁻⁶) of Staphylococcus aureus was gently applied. 7 After the bacterial solution was completely absorbed (CFU / mL) for 1 min, the wound was covered with sterile gauze. The constructed infected burn SD rats were divided into 4 groups, and the wounds of the SD rats were treated with physiological saline, Gel 1, Gel 2, and Dual-Gel, respectively. A 633nm continuous laser (200mW / cm²) was then used to treat the wounds. 2 After irradiation (15 min), the wounds were individually housed for 14 consecutive days. The wound healing process (including exudation, eschar dissolution, granulation tissue, and new epidermis) was observed and recorded daily, and photographs were taken for documentation.

[0093] Figure 13 The figures show the wound healing effects of different treatment groups. As can be seen from the figures, compared with the control group, Gel1, Gel2, and Dual-Gel groups all effectively promoted wound healing, with the Dual-Gel group showing the best healing effect, with significant results observed as early as day 8. This indicates that stem cell vesicle hydrogels can not only promote wound healing by regulating reactive oxygen species, but also that stem cell vesicles can promote tissue repair. These results demonstrate the potential application value of the healing-promoting material of this invention in the field of wound treatment.

[0094] The technical solutions provided by the embodiments of the present invention have been described in detail above. Specific examples have been used to illustrate the principles and implementation methods of the embodiments of the present invention. The descriptions of the embodiments above are only for helping to understand the principles of the embodiments of the present invention. At the same time, for those skilled in the art, there will be changes in the specific implementation methods and application scope based on the embodiments of the present invention. Therefore, the content of this specification should not be construed as a limitation of the present invention.

Claims

1. A stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration, characterized in that: It is a bilayer gel, consisting of an upper hydrogel Gel 1 that is reactive oxygen species responsive and a lower hydrogel Gel 2 that is loaded with stem cell vesicles containing AIE nanoparticles. The structural formula of the AIE molecule in the AIE nanoparticles is shown in formula (I): Formula (I); The lower hydrogel Gel 2 is formed by hydrogen bonding of sodium hyaluronate and loaded with stem cell vesicles containing AIE nanoparticles; The maximum concentration of AIE nanoparticles in the stem cell vesicles containing AIE nanoparticles does not exceed 400 μmol / L.

2. The stem cell vesicle hydrogel according to claim 1, characterized in that: The protein concentration range of the AIE nanoparticle-containing stem cell vesicles is 1–500 μg / mL; The reactive oxygen species responsive upper hydrogel Gel 1 is prepared by click reaction covalent crosslinking of a water-soluble polymer compound containing thiol groups, a water-soluble polymer compound containing alkynyl groups, and a reactive oxygen species responsive molecular compound containing amino functional groups.

3. A method for preparing a stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration as described in any one of claims 1-2, characterized in that: The steps include: S1. Preparation of AIE nanoparticles: DSPE-PEG solution was slowly added dropwise to a dimethyl sulfoxide solution containing AIE molecules under stirring. After stirring, the solution was dialyzed overnight, and AIE nanoparticles were collected. Preparation of S2.AIE@EVs vesicles: After lysing stem cells to obtain cell membrane suspension, the cell membrane suspension was repeatedly ground, the supernatant was collected by centrifugation, and the supernatant was repeatedly squeezed and sieved using a liposome extruder to obtain artificial stem cell vesicles; AIE nanoparticles and artificial stem cell vesicles are co-incubated and then sieved by reciprocating extrusion using a liposome extruder to achieve the encapsulation of AIE nanoparticles by artificial stem cell vesicles, thereby obtaining a stem cell vesicle solution containing AIE nanoparticles, also known as AIE@EVs vesicle solution. S3. AIE@EVs vesicle solution was mixed with sodium hyaluronate powder and incubated, then allowed to stand and solidify to obtain a lower hydrogel loaded with AIE@EVs vesicles; S4. Prepare a water-soluble polymer compound containing an alkyne group. Mix the water-soluble polymer compound containing a thiol group with the water-soluble polymer compound containing an alkyne group and a reactive oxygen species responsive molecular compound containing an amino functional group, and then rapidly drop the mixture onto the lower hydrogel. Allow it to stand and solidify to obtain the stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote wound regeneration.

4. The method for preparing a stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration according to claim 3, characterized in that: The detailed preparation process of the S1.AIE nanoparticles includes: slowly adding 6 mL of a solution containing 6 mg DSPE-PEG dropwise to 300 μL of a dimethyl sulfoxide solution containing 2 mg AIE molecules under stirring conditions, stirring for 30 minutes, dialyzing overnight, and collecting AIE nanoparticles.

5. The method for preparing a stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration according to claim 3, characterized in that: The detailed preparation process of the S2.AIE@EVs vesicles includes: adding hypotonic cell lysis buffer to the stem cell suspension, lysing overnight at 4 ℃ to obtain a cell membrane suspension, repeatedly grinding the cell membrane suspension, centrifuging at 3200 g and 4 ℃ for 5 min, taking the supernatant, and repeatedly extruding and sieving it through a liposome extruder using Millipore polycarbonate membranes with pore sizes of 800 nm and 400 nm to obtain artificial stem cell vesicles with a diameter of approximately 300 nm; incubating AIE nanoparticles and artificial stem cell vesicles at a mass ratio of 2:1 at room temperature for 30 min, and repeatedly extruding and sieving them through a liposome extruder using a Millipore polycarbonate membrane with a pore size of 200 nm to achieve the encapsulation of AIE nanoparticles by artificial stem cell vesicles, and purifying to obtain AIE@EVs vesicles with a diameter of 100-200 nm; Artificial stem cell vesicles are derived from one or more of adipose stem cells, bone marrow stem cells, and human umbilical cord mesenchymal stem cells.

6. The method for preparing a stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration according to claim 3, characterized in that: The detailed process of S3 includes: using an AIE@EVs vesicle solution with a protein concentration of 1-500 μg / mL as a hydrogel precursor solution, mixing it with sodium hyaluronate powder at a mass ratio of 100:3-100:5, incubating at 37 ℃ for 30 min, and then allowing it to stand at room temperature for 30 min to solidify, thereby obtaining a lower layer hydrogel loaded with AIE@EVs vesicles.

7. The method for preparing a stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration according to claim 3, characterized in that: The thiol-containing water-soluble polymer compound has one of the following structures: ; ; Where n is an integer greater than or equal to 1; The water-soluble polymer containing an alkyne group has one of the following structures: ; ; ; Where n is an integer greater than or equal to 1; Reactive oxygen species responsive molecular compounds containing amino functional groups have one of the following structures: ; 。 8. The method for preparing a stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration according to claim 7, characterized in that: The detailed process of S4 includes: mixing a water-soluble polymer compound containing thiol groups, a water-soluble polymer compound containing alkynyl groups, and a reactive oxygen species responsive molecular compound containing amino functional groups in a molar ratio of 1:0.3:0.35-1:0.5:0.125, mixing them under pH=7-9 conditions, and then rapidly dropping the mixture onto the lower hydrogel. After standing and solidifying for 3 min, the stem cell vesicle hydrogel that can programmatically regulate tissue reactive oxygen species and promote tissue regeneration is obtained. The water-soluble polymer containing thiol groups is 8-arm-PEG-SH; The alkyne-containing water-soluble polymer compound is PEG4000-DA, and its preparation process includes: dissolving 2.5 mmol PEG-4000, 25 mmol propargyl acid, and a catalytic amount of 1.5 mmol p-toluenesulfonic acid in toluene, stirring the mixed solution and refluxing for 48 h, continuously removing the generated water, then concentrating the solution under vacuum, purifying it, and drying it under vacuum to obtain the alkyne-containing water-soluble polymer compound PEG4000-DA; The reactive oxygen species-responsive molecular compound containing an amino functional group is TK-linker, and its structural formula is as follows: ; Where n is an integer greater than or equal to 1.

9. The application of a stem cell vesicle hydrogel as described in any one of claims 1-2, which can programmatically regulate tissue reactive oxygen species and promote tissue regeneration, in the preparation of wound repair and regeneration materials.

Citation Information

Patent Citations

  • Preparation method of in-situ nano composite hydrogel capable of controllably releasing medicine

    CN116370402A

  • Photodynamic anti-infection artificial stem cell vesicle hydrogel for promoting wound repair as well as preparation method and application of photodynamic anti-infection artificial stem cell vesicle hydrogel

    CN116392588A